Pharmaceutical Technology

MAY 30, 2023

According to GlobalData’s Looking Ahead to 2023 – the Future of Pharma report, five drugs set for approval in 2023 are projected to attain blockbuster status or near-blockbuster status by 2028 with US company dominance. These drugs are set to make a combined $4.34bn in sales in 2028. Similarly, Almirall S.A.,

Sales 105

Sales Marketing Prescription Pharma 105

World of DTC Marketing

MAY 19, 2021

While AbbVie is a poster for everything wrong with pharma, what they have done doesn’t apply to ALL pharma companies. The cost of Humira, which is injected via syringe, was more than $72,000 a year on prescription drug websites this week and is not expected to come down until at least 2023. ” Rep Katie Porter.

Pharma 181

Pharma Prescription Patients Pharmaceutical 181

Pharma Marketing Network

OCTOBER 26, 2022

Join Reuters Events’ exclusive panel discussion to hear experts from Novartis, Takeda and Janssen share business-critical learnings, including: Differentiate predictive vs prescriptive insights and inform your next best action. The post Pharma USA 2023 | March 28–29, 2023 appeared first on Pharma Marketing Network.

Pharma 52

Pharma Prescription Marketing Networking 52

Pharmaceutical Technology

JANUARY 30, 2023

on National Health Service (NHS) sales of branded medicines in 2023, almost double that of the previous year, has sent shock waves through the pharma industry. During 2019–21, when sales being close to predicted levels resulted in single-digit payback rates, the scheme was relatively popular with the pharma sector. billion ($4.1

Government 97

Government Pharma Sales Medicine 97

PM360

SEPTEMBER 21, 2023

Jeff Casberg, MS, RPh, Senior Vice President of Clinical Pharmacy at IPD Analytics, a managed care and pharmaceutical consultancy, highlighted a wide range of 2023 key events that will affect managed care professionals by the end of the year. This product is expected to have three generic launches in 2023.

Management 105

Management Manufacturing Sales Competition 105

PharmExec

APRIL 14, 2023

Using prescription digital therapeutics can lead to better outcomes for patients, making them a win-win for pharma and patients.

Pharma 52

Pharma Prescription Leads Patients 52

World of DTC Marketing

MARCH 10, 2022

The cost of Humira, which is injected via syringe, was more than $72,000 a year on prescription drug websites this week and is not expected to come down until at least 2023. The increase followed total Humira price hikes of 19 percent during 2017 and 2018. The executives at AbbVie make over $300 million.

Prescription 205

Prescription Pharmaceutical products Pharmaceutical Marketing 205

PM360

MAY 15, 2023

After a developmental day of shadowing a pharma sales rep, the fire was lite and she joined the sales team never looking back, ultimately landing her a role at ConnectiveRx in 2010. Laura is not shy about sharing her cancer experience. Laura has educated the new ConnectiveRx employees on the “real” patient journey.

Sales 94

Sales Pharma sales reps Prescription Recruitment 94

PM360

DECEMBER 14, 2023

Survey any physician if they’ve been asked by a patient about a prescription weight loss medication and you’ll hear a resounding “yes.” The recent Sermo Barometer confirms that 89% of 300+ global practitioners have seen an increase in patients proactively requesting prescription weight loss medications.

Medical 105

Medical Side effects Physicians Prescription 105

PM360

APRIL 7, 2023

This is especially significant for manufacturers of high-cost specialty drugs, who will now face a recurring additional 20% charge on virtually every prescription fill. pharma sales in 2020) and the size of 340B discounts (25-50%), companies may see significantly reduced revenues for important products. The 340B battle will rage on.

Manufacturing 97

Manufacturing Insurance Government Marketing 97

PM360

NOVEMBER 12, 2023

Technological innovations and changes in consumer behavior over the past 10 years have reduced friction, saved time, and opened new options for consumers and patients seeking routine prescriptions and refills via telehealth. Pharma marketing campaigns have traditionally been brand awareness oriented, with limited direct conversion potential.

Prescription 52

Prescription Media Pharma Patients 52

Pharmaceutical Technology

JUNE 21, 2023

AGEPHA Pharma has received approval from the US Food and Drug Administration (FDA) for LODOCO (colchicine, 0.5 The company expects to launch LODOCO for prescription use in the second half of 2023. mg tablet) to treat cardiovascular disease.

Food and Drug Administration 98

Food and Drug Administration FDA Prescription Food 98

pharmaphorum

DECEMBER 15, 2022

A pharma industry organisation has warned that record levels of revenue clawback from the UK government is threatening “footprint, R&D and manufacturing investments” in the country. “The industry now regards the current approach, due to end in 2023, as broken.” VPAS tax on top. .” VPAS tax on top.

Pharma 72

Pharma Government Manufacturing Medicine 72

European Pharmaceutical Review

APRIL 21, 2023

6 Article: Five potential EU regulatory changes impacting the life sciences industry in 2023 … Scrutinising the supply chain An important but often opaque consideration is the supply chains in non-EU countries, which play a predominant role especially in the production of generic drugs and antibiotics. Baltruks D, Sowa M, Voss M.

Pharma 98

Pharma Food and Drug Administration Medicine Pharmaceutical 98

PM360

JULY 13, 2023

By fostering cross-stakeholder coordination and support across pharma brands, HCPs, pharmacies, and insurance companies, we can pave the way for better solutions that enhance adherence and, ultimately, improve patient outcomes. What if the industry were to incentivize persistence over new prescriptions?

Patients 98

Patients Medical Education Transportation 98

PM360

OCTOBER 13, 2023

Doctor Docs: Targeting Trust Between Pharma and HCPs A new study shows the crucial link in pharma marketers’ digital engagement strategy with HCPs is in jeopardy—trust. and France regarding pharma-provided digital platforms. One participant summed up these perceptions by stating “It’s a pharmaceutical site, you know.

Healthcare 59

Healthcare Healthcare Doctors Pharma 59

Pharmaceutical Technology

MARCH 17, 2023

This is partly due to the differing business models used by pharma companies and digital therapeutic developers. Prescription digital therapeutics must go through regulatory agencies and have clinical data, says Chris Wasden, chief strategy officer (CSO) of Twill Health, a US-based digital therapeutics company.

Prescription 111

Prescription Pharmacology Pharma Medical 111

Eversana Intouch

JANUARY 19, 2023

Success in 2023 will mean addressing each of those five issues meaningfully – understanding them fully and giving them real action, not just lip service. Pharma marketers in 2023 need to: Look for blind spots. Each year, we forecast several trends that will influence life-sciences marketing the most in the months to come ahead.

Medical 52

Medical Education Competition Marketing 52

Pharmaceutical Technology

DECEMBER 15, 2022

They requested recognition that the prescription medicines sector is critical in the EU and that national emergency plans for gas/oil supplies should apply, reducing the complexity and cost of regulatory compliance and reform of medicines procurement and pricing models. Inflation can damage production viability of European drugs.

Transportation 98

Transportation Medicine Manufacturing Pharma 98

PM360

AUGUST 9, 2022

The combined solution enables health plans and self-insured employers to realize immediate pharmacy cost savings and near-term medical cost reductions by integrating Levrx’s plan-specific and real-time prescription insights into the Adhere Platform medication optimization offerings. Pharma Manufacturer Solutions. Vincent Keunen.

Prescription 105

Prescription Medical Patients Side effects 105

European Pharmaceutical Review

NOVEMBER 8, 2022

In the current US Congressional session, Congress has focused heavily on legislation directed at reducing prescription drug prices. 1435 (“Affordable Prescriptions for Patients Act of 2021”), [link] gov/bill/117th-congress/senate-bill/1435/text; H.R. Actavis, 570 U.S. 136 (2013), [link] opinions/12pdf/12-416_m5n0.pdf.

Food and Drug Administration 52

Food and Drug Administration Pharma Manufacturing Prescription 52

pharmaphorum

OCTOBER 24, 2022

A sweetened offer from Sumitomo Pharma has convinced endocrinology specialist Myovant to agree to a takeover, after its first was rejected. “Myovant’s two products…have substantial potential,” said Sumitomo Pharma’s chief executive Hiroshi Nomura. The stock hit just under $25 in trading today.

Biopharma 75

Biopharma Marketing Pharma Prescription 75

Eversana Intouch

FEBRUARY 23, 2023

Let’s talk about the current economic uncertainty and what it means for pharma marketers. We heard it from pharmaceutical executives, who see inflation as their top concern in 2023; from economists we interviewed; and most importantly, from patients, in a recent survey of 200 American patients that EVERSANA INTOUCH conducted.

Marketing 52

Marketing Pharma Patients Insurance 52

Eversana Intouch

FEBRUARY 23, 2023

Let’s talk about the current economic uncertainty and what it means for pharma marketers. We heard it from pharmaceutical executives, who see inflation as their top concern in 2023; from economists we interviewed; and most importantly, from patients, in a recent survey of 200 American patients that EVERSANA INTOUCH conducted.

Marketing 52

Marketing Pharma Patients Insurance 52

Healthcare Success

NOVEMBER 7, 2022

They’re researching key trends that will attract new high-intent audiences, increase engagement, drive revenue, and reinforce patient loyalty in 2023. In this article, you’ll learn: 4 Advertising Planning Strategies for 2023 6 Marketing Strategies That Outpace Market Disruption. 4 Advertising Planning Strategies for 2023.

Marketing 52

Marketing Media Healthcare Healthcare 52

pharmaphorum

NOVEMBER 16, 2022

Walmart has become the latest big pharmacy chain in the US to put forward a settlement to resolve claims it contributed to the national opioid crisis by failing to regulate prescriptions at its outlets. billion for Mallinckrodt , and $450 million for Endo Pharma. The retail giant has confirmed it has offered $3.1

Prescription 52

Prescription Government Retail Pharma 52

PM360

NOVEMBER 13, 2023

Improving healthcare and patient outcomes requires that stakeholders communicate and collaborate, and GoodRx is one of the few places where providers, patients, and pharma can connect every single day. 3 For those who think trust is a “soft” metric, here are some hard numbers. How are they different?

Media 52

Media Prescription Healthcare Provider Patients 52

Contrarian Sales Techniques

FEBRUARY 24, 2023

For instance… I would like to share an idea with you that I believe has great potential for local pharma companies in the current business landscape. I believe that the telemedicine industry presents a significant opportunity for pharma companies to expand their business and contribute to improving healthcare services in the country.

Medical sales reps 52

Medical sales reps Medical sales Medical Sales 52

European Pharmaceutical Review

JANUARY 25, 2024

It emphasises its ability to make information interoperable with electronic health systems such as e-prescription and electronic health records. References European Commission, (26 April 2023). Euractiv (6 October 2023). European Commission (26 April 2023). Article 63 Euractiv (26 September 2023).

Healthcare 98

Healthcare Healthcare Safety Electronics 98

PM360

JULY 13, 2023

Launched in April 2023, BrightInsight’s PSP+ Companion App, built on the compliant BrightInsight Platform, connects patients to the resources they need to complete prior authorization, register for financial assistance, understand and track their therapies, and much more. But outdated manual processes are complex and leave many patients out.

Education 89

Education Medical Patients Media 89

PM360

SEPTEMBER 21, 2023

As a mission-driven company and digital healthcare leader, GoodRx has helped patients obtain an estimated 80 million prescriptions they otherwise may not have been able to afford. Figure 1: Share of net spending for specialty and traditional prescription medications. Households in 2022,” May 2023. 7 Figure 3: Share of U.S.

Prescription 52

Prescription Medical Patients Distribution 52

PM360

APRIL 7, 2023

With new “disruptive” market entrants, how does the PBM landscape change, how are consumer perceptions altered, and how do pharma marketers stay ahead of the game to deliver differentiated value for brands? This program, powered by GoodRx, bills itself as: “Free prescriptions, plus hundreds of prescriptions for $6 or less with membership.”

Marketing 52

Marketing Prescription Insurance Retail 52

Pharmaceutical Technology

FEBRUARY 1, 2023

Among the many competitors in this space, seven companies are in Phase III trials and some may face regulatory decisions in 2023. Currently, GSK’s GSK 3844766A (RSVPreF3 OA) and Pfizer’s vaccine candidate RSVpreF (PF-06928316) may reach FDA approval first, having Prescription Drug User Fee Act (PDUFA) dates of May 3 and May 31, respectively.

Pharma 64

Pharma Pharmaceutical Patients Healthcare Provider 64

PM360

DECEMBER 14, 2022

that didn’t stop us from asking 10 industry experts to take their best shot at anticipating what to expect in 2023 and beyond. So, in order to help best prepare you for what might come, we asked these 10 individuals to peer into their crystal balls and let us know: What will be the biggest trend(s) marketers will be talking about in 2023?

Marketing 91

Marketing Patients Healthcare Healthcare 91

Pharmaceutical Technology

OCTOBER 31, 2022

The regulator has set 29 August 2023 as a Prescription Drug User Fee Act (PDUFA) goal date. The company has also established partnerships with Ajinomoto Bio-Pharma Services for finished drug products and with FUJIFILM Diosynth Biotechnologies for drug substance manufacturing.

Food and Drug Administration 59

Food and Drug Administration FDA Distribution Prescription 59

Clarivate

JULY 5, 2023

biologics market and reduce prescription drug costs. When AMJETIVA finally launched at the end of January 2023, its unusual, tiered pricing strategy made headlines. from 91% in 2023 to 36% by 2031. By end of year, as many as ten adalimumab biosimilars could be on the U.S. In 2022, it made its manufacturer, AbbVie, $21.2bn.

Marketing 97

Marketing Physicians Manufacturing Competition 97

Pharmaceutical Technology

MAY 24, 2023

Whilst the pharma industry has been relatively slow in developing new treatments – an array of legal challenges posed to pharma companies and pharmacies implicated in the crisis still trundles on. The year 2023 has seen some landmark regulatory developments to contain the crisis.

FDA 59

FDA Food and Drug Administration Prescription Medical 59